Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST)

Bone Marrow Transplantation

Volumn 32, Issue 11, 2003, Pages 1089-1095

  Yamamoto, R ^a   Kusumi, E ^b   Kami, M ^a   Yuji, K ^b   Hamaki, T ^a   Saito, A ^a   Murasgihe, N ^a   Hori, A ^a   Kim, S W ^a   Makimoto, A ^a   Ueyama, J ^b   Tanosaki, S ^a   Miyakoshi, S ^b   Mori, S ^a   Morinaga, S ^b   Heike, Y ^a   Taniguchi, S ^b   Masuo, S ^c   Takaue, Y ^a   Mutou, Y ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c JR Tokyo General Hospital   (Japan)

Author keywords

Adenovirus; Hemorrhagic cystitis; Reduced intensity stem cell transplantation

Indexed keywords

BUSULFAN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; METHOTREXATE; METHYLPREDNISOLONE; PENTAMIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THYMOCYTE ANTIBODY; VIRUS ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS; ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BK VIRUS; BLOOD CLOTTING; BLOOD TRANSFUSION; CHILD; CHRONIC GRAFT REJECTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREQUENCY ANALYSIS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NEPHROLITHIASIS; PRIORITY JOURNAL; PROBABILITY; SOLID TUMOR; T CELL LEUKEMIA; T CELL LYMPHOMA; UROGENITAL TRACT CANCER; VIRUS INFECTION;

ADENOVIRIDAE; ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYSTITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC DISORDERS; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0346121544     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704261     Document Type: Article

References (38)

1. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531-4536.
2. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cyto-reduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-763.
3. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem cell transplantation. N Engl J Med 2000; 343: 750-758.
4. Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817-2824.
5. Saito T, Kanda Y, Kami M et al. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. Clin Cancer Res 2002; 8: 1014-1020.
6. McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390-3400.
7. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993; 56: 875-879.
8. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983; 309: 1347-1353.
9. Brugieres L, Hartmann O, Travagli JP et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 1989; 7: 194-199.
10. Bedi A, Miller CB, Hanson JL et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103-1109.
11. Yang CC, Hurd DD, Case LD et al. Hemorrhagic cystitis in bone marrow transplantation. Urology 1994; 44: 322-328.
12. Haselberger MB, Schwinghammer TL. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Ann Pharmacother 1995; 29: 918-921.
13. Thomas AE, Patterson J, Prentice HG et al. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy. Bone Marrow Transplant 1987; 1: 347-355.
14. Ringden O, Labopin M, Tura S et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996; 93: 637-645.
15. Arthur RR, Shah KV, Baust SJ et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230-234.
16. Ost L, Lonnqvist B, Eriksson L et al. Hemorrhagic cystitis - a manifestation of graft versus host disease? Bone Marrow Transplant 1987; 2: 19-25.
17. Appelbaum FR, Barrall J, Storb R et al. Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. Ann Intern Med 1990; 112: 590-597.
18. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
19. Niiya H, Kanda Y, Saito T et al. Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan. Haematologica 2001; 86: 1071-1074.
20. Przepiorka D, Weisdorf D, Martin P et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 823-828.
21. Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250-259.
22. Kanda Y, Mineishi S, Nakai K et al. Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin. Blood 2001; 97: 3676-3677.
23. Kanda Y, Mineishi S, Saito T et al. Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation. Transplantation 2002; 73: 568-572.
24. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323-1332.
25. Akiyama H, Kurosu T, Sakashita C et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32: 1325-1330.
26. Miyamura K, Takeyama K, Kojima S et al. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 533-535.
27. Childs R, Sanchez C, Engler H et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998; 22: 889-893.
28. Kohno A, Takeyama K, Narabayashi M et al. Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults. Jpn J Clin Oncol 1993; 23: 46-52.
29. Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35-40.
30. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 1982; 20: 256-258.
31. Kondo M, Kojima S, Kato K et al. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 1998; 22: 995-998.
32. Runde V, Ross S, Trenschel R et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28: 51-57.
33. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985; 312: 529-533.
34. Russell SJ, Vowels MR, Vale T. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 1994; 13: 533-539.
35. Trotman J, Nivison-Smith I, Dodds A. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant 1999; 23: 797-801.
36. Bacigalupo A, Lamparelli T, Bruzzi P et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98: 2942-2947.
37. Atkinson K, Biggs J, Noble G et al. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oropharyngeal mucositis. Bone Marrow Transplant 1987; 2: 385-394.
38. Millard RJ. Busulfan-induced hemorrhagic cystitis. Urology 1981; 18: 143-144.